Mei Pharma, Inc.

This early-phase study tested a new drug called voruciclib, alone or combined with another drug (venetoclax), in adults with certain blood cancers (like lymphoma or leukemia) that returned or didn't respond to standard treatments. The main goal was to check safety and find the ri…